Suppression of DAPK1 reduces ischemic brain injury through inhibiting cell death signaling and promoting neural remodeling
Brain Research · 2023
DOI: 10.1016/j.brainres.2023.148588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2023. Verfasst von Jinyoung Won und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Science, Graduate School of Inje University, Gimhae, South Korea; Biohealth Products Research Center (BPRC), Inje Univer…. Hauptthemen laut MEDLINE: Death-Associated Protein Kinases, Brain Ischemia, Neuronal Plasticity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The role of death-associated protein kinase1 (DAPK1) in post-stroke functional recovery is controversial, as is its mechanism of action and any neural remodeling effect after ischemia. To assess the debatable role of DAPK1, we established the middle cerebral artery occlusion (MCAo) model in DAPK1 knockout mice and Sprague-Dawley (SD) rats. We identified that the genetic deletion of the DAPK1 as well as pharmacological inhibition of DAPK1 showed reduced brain infarct volume and neurological deficit. We report that DAPK1 inhibition (DI) reduces post-stroke neuronal death by inhibiting BAX/BCL2 and LC3/Beclin1 mediated apoptosis and autophagy, respectively. Histological analysis displayed a reduction in nuclear condensation, neuronal dissociation, and degraded cytoplasm in the DI group. The DI treatment showed enhanced dendrite spine density and neurite outgrowth, upregulated neural proliferation marker proteins like brain-derived neurotrophic factor, and reduced structural abnormalities of the cortical pyramidal neurons. This research shows that DAPK1 drives cell death, its activation exacerbates functional recovery after cerebral ischemia and shows that oxazolone-based DI could be an excellent candidate for stroke and ischemic injury intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Science, Graduate School of Inje University, Gimhae, South Korea; Biohealth Products Research Center (BPRC), Inje University, Gimhae, South Korea; Research Center for Aged-life Redesign (RCA…
- Biohealth Products Research Center (BPRC), Inje University, Gimhae, South Korea; Research Center for Aged-life Redesign (RCAR), Inje University, Gimhae, South Korea; Department of Physical Therapy, College of Healthcare…
- Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Science, Fujian Medical University, Fuzhou, China.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Won, J., Lee, S., Ahmad Khan, Z., Choi, J., Ho Lee, T., & Hong, Y. (2023). Suppression of DAPK1 reduces ischemic brain injury through inhibiting cell death signaling and promoting neural remodeling. Brain Research. https://doi.org/10.1016/j.brainres.2023.148588
Vancouver
Won J, Lee S, Ahmad Khan Z, Choi J, Ho Lee T, Hong Y. Suppression of DAPK1 reduces ischemic brain injury through inhibiting cell death signaling and promoting neural remodeling. Brain Research. 2023. doi:10.1016/j.brainres.2023.148588
BibTeX
@article{Won2023,
author = {Won, Jinyoung and Lee, Seunghoon and Ahmad Khan, Zeeshan and Choi, Jeonghyun and Ho Lee, Tae and Hong, Yonggeun},
title = {Suppression of DAPK1 reduces ischemic brain injury through inhibiting cell death signaling and promoting neural remodeling},
journal = {Brain Research},
year = {2023},
doi = {10.1016/j.brainres.2023.148588}
}
EUVIMED